Literature DB >> 20171700

Decreasing electrosurgical transurethral resection of the prostate surgical volume during graduate medical education training is associated with increased surgical adverse events.

Jaspreet S Sandhu1, William I Jaffe, Doreen E Chung, Steven A Kaplan, Alexis E Te.   

Abstract

PURPOSE: In the United States the numbers of electrosurgical transurethral prostate resection procedures have been decreasing. Since electrosurgical transurethral resection of the prostate is a difficult procedure to master, we hypothesized that recent residents are lacking in training for this procedure. We used summary case log information provided by the Accreditation Council for Graduate Medical Education to determine if the number of electrosurgical transurethral prostate resection procedures performed by graduating chief residents has decreased and if there has been an increase in surgical adverse events. In addition, we investigated whether the increased number of laser procedures impacted the rate of adverse events.
MATERIALS AND METHODS: Summary operative data from graduating chief resident case logs were provided by the Accreditation Council for Graduate Medical Education for academic years 2001 to 2007. The numbers of electrosurgical transurethral prostate resection procedures, laser procedures and procedures for adverse events were recorded for each year.
RESULTS: The number of electrosurgical transurethral prostate resection procedures performed by graduating chief residents has steadily decreased from 58 in 2001 to 43 in 2007. Conversely the number of laser procedures started increasing in 2004. The rate of procedures for adverse events as a percentage of electrosurgical transurethral resection of the prostate procedures increased during the study period (from 3% in 2001 to 6% in 2007), and as a percentage of electrosurgical transurethral resection of the prostate and laser procedures the rate increased until 2005 and subsequently started decreasing.
CONCLUSIONS: The rate of surgical adverse events, as measured by the need for subsequent procedures, has increased during the last 7 years. However, when laser procedures are accounted for, it appears that adverse events have recently started trending down as an increasing number of laser procedures started being performed. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2010        PMID: 20171700     DOI: 10.1016/j.juro.2009.12.025

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Analysis of the learning curve for transurethral resection of the prostate. Is there any influence of musical instrument and video game skills on surgical performance?

Authors:  Kleiton Gabriel Ribeiro Yamaçake; Elcio Tadashi Nakano; Iva Barbosa Soares; Paulo Cordeiro; Miguel Srougi; Alberto Azoubel Antunes
Journal:  Turk J Urol       Date:  2015-09

2.  Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States.

Authors:  William T Lowrance; Andrew Southwick; Alexandra C Maschino; Jaspreet S Sandhu
Journal:  J Urol       Date:  2012-12-03       Impact factor: 7.450

3.  Selective transurethral resection of the prostate combined with transurethral incision of the bladder neck for bladder outlet obstruction in patients with small volume benign prostate hyperplasia (BPH): a prospective randomized study.

Authors:  Xin Li; Jin-hong Pan; Qi-gui Liu; Peng He; Si-ji Song; Tao Jiang; Zhan-song Zhou
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

4.  Comparison of Photoselective Vaporization versus Holmium Laser Enucleation for Treatment of Benign Prostate Hyperplasia in a Small Prostate Volume.

Authors:  Kang Sup Kim; Jin Bong Choi; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sang Hoon Kim; Hyun Woo Kim; Su Yeon Cho; Sae Woong Kim
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.